Evidence map›Paper›PMID 26483157›Full record

ArticleCellular signalling2016

Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.

Michelle C Helms, Elda Grabocka, Matthew K Martz, Christopher C Fischer, Nobuchika Suzuki, Philip B Wedegaertner

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  6. Regulating Rho GTPases and their regulators.Nature reviews. Molecular cell biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Michelle C HelmsDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Elda GrabockaDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Matthew K MartzDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Christopher C FischerDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Nobuchika SuzukiDepartment of Signal Dynamics, University of Tokyo, Meguro, Tokyo, Japan.
Philip B WedegaertnerDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: philip.wedegaertner@jefferson.edu.
Thomas Jefferson University · USThe University of Tokyo · JP

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
SIGNALING THROUGH RHO GTP/GDP EXCHANGE FACTORSR01GM062884 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI WEDEGAERTNER, PHILIP B · 2001 to 2013
$3.4M
NCI NIH HHS P30 CA056036NIGMS NIH HHS GM62884NIGMS NIH HHS R01 GM062884
6 · The paper itself

Abstract

Rho GTPases are integral to the regulation of actin cytoskeleton-dependent processes, including mitosis. Rho and leukemia-associated Rho guanine-nucleotide exchange factor (LARG), also known as ARHGEF12, are involved in mitosis as well as diseases such as cancer and heart disease. Since LARG has a role in mitosis and diverse signaling functions beyond mitosis, it is important to understand the regulation of the protein through modifications such as phosphorylation. Here we report that LARG undergoes a mitotic-dependent and cyclin-dependent kinase 1 (Cdk1) inhibitor-sensitive phosphorylation. Additionally, LARG is phosphorylated at the onset of mitosis and dephosphorylated as cells exit mitosis, concomitant with Cdk1 activity. Furthermore, using an in vitro kinase assay, we show that LARG can be directly phosphorylated by Cdk1. Through expression of phosphonull mutants that contain non-phosphorylatable alanine mutations at potential Cdk1 S/TP sites, we demonstrate that LARG phosphorylation occurs in both termini. Using phosphospecific antibodies, we confirm that two sites, serine 190 and serine 1176, are phosphorylated during mitosis in a Cdk1-dependent manner. In addition, these phosphospecific antibodies show phosphorylated LARG at specific mitotic locations, namely the mitotic organizing centers and flanking the midbody. Lastly, RhoA activity assays reveal that phosphonull LARG is more active in cells than phosphomimetic LARG. Our data thus identifies LARG as a phosphoregulated RhoGEF during mitosis.

Indexed as

Actin CytoskeletonCDC2 Protein KinaseHeLa CellsHumansLeukemiaMitosisPhosphorylationrhoA GTP-Binding Proteinrho GTP-Binding ProteinsRho Guanine Nucleotide Exchange FactorsARHGEF12 protein, humanCDC2 Protein KinaserhoA GTP-Binding Proteinrho GTP-Binding ProteinsRho Guanine Nucleotide Exchange FactorsCdk1CytokinesisMitosisPhosphorylationRhoARhoGEFSubcellular localization

Identifiers

PMID26483157
PMCPMC4679667
OpenAlexW2114686722

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.